Table 2.
Comparison of evaluated demographic and routine laboratory results in SARS-CoV-2 seropositive and seronegative groups with kidney transplant.
| SARS-CoV-2 Seronegative (n = 97) |
SARS-CoV-2 Seropositive (n = 39) |
p | |||
|---|---|---|---|---|---|
| Mean (s) | Median (Min–Max) |
Mean (s) | Median (Min–Max) |
||
| Age, years | 53 (13) | 55 (25–74) | 52 (14) | 55 (21–82) | 0.6 |
| Years after transplantation | 6.1 (4.6) | 5.5 (0.3–20.7) | 7.4 (5.1) | 5.8 (0.9–21.8) | 0.2 |
| Creatinine before vaccination (mcmol/L) | 145 (63) | 123 (68–446) | 116 (45) | 110 (51–246) | 0.004 |
| eGFR * before vaccination (mL/min/1.73 m2) | 49 (18) | 50 (15–102) | 64 (22) | 59 (23–117) | <0.001 |
| Hemoglobin before vaccination (g/L) | 132 (15) | 132 (84–185) | 142 (14) | 141 (114–176) | <0.001 |
| Creatinine after vaccination (mcmol/L) | 150 (66) | 128 (68–435) | 121 (48) | 113 (22–118) | 0.012 |
| eGFR * after vaccination (mL/min/1.73 m2) | 47 (18) | 46 (15–96) | 62 (24) | 61 (22–118) | <0.001 |
| Hemoglobin after vaccination (g/L) | 134 (14) | 134 (101–169) | 142 (14) | 141 (119–173) | 0.004 |
| Immunoglobulin G (g/L) | 8.4 (2.9) | 8.4 (0.3–17) | 9.6 (3.1) | 9.8 (0.8–17) | 0.035 |
*—estimated glomerular filtration rate (eGFR).